Vimarsana
Biggest News Aggregation in the World

Page 2 - Lawrence Eichenfield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lawrence Eichenfield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lawrence Eichenfield Today - Breaking & Trending Today

Study Finds Multidisciplinary Pediatric AD Clinic Beneficial - Vimarsana News

Study Finds Multidisciplinary Pediatric AD Clinic Beneficial

The clinic is a collaborative effort between Rady Children's Hospital and the University of California San Diego Health Divisions of Dermatology, Allergy & Immunology, and the hospital's pharmacy.

Vast Majority of Atopic Dermatitis Patients Show EASI Improvement with 4 Weeks of Roflumilast Cream - Vimarsana News

Vast Majority of Atopic Dermatitis Patients Show EASI Improvement with 4 Weeks of Roflumilast Cream

These data, presented at the Winter Clinical conference, showed that roflumilast cream 0.15% led to positive results for patients with eczema.

Dermatology Month in Review: November 2023 - Vimarsana News

Dermatology Month in Review: November 2023

The Dermatology Month in Review for dermatology features 2 interviews, findings from recent long-term data, and a discussion of the FDA’s approval of secukinumab for HS.

Lawrence Eichenfield, MD: Long-Term Disease Control with Ruxolitinib Cream for Atopic Dermatitis - Vimarsana News

Lawrence Eichenfield, MD: Long-Term Disease Control with Ruxolitinib Cream for Atopic Dermatitis

This discussion with Dr. Eichenfield featured coverage of data on ruxolitinib for eczema patients.

Lawrence Eichenfield, MD: Comparing Ruxolitinib, Other Atopic Dermatitis Treatments - Vimarsana News

Lawrence Eichenfield, MD: Comparing Ruxolitinib, Other Atopic Dermatitis Treatments

In this interview with Dr. Eichenfield, comparisons between ruxolitinib and other treatments for eczema were discussed.